The FDA has been analyzing the new J&J vaccine, a single shot vaccine that is shown to protect against COVID and some of its variants and doesn’t need to be stored in sub-freezing temperatures. If it receives emergency use authorization this Friday as expected, this could speed up the vaccination efforts around the world.
Reports show that the J&J offers more protection against new, deadly variants — 68 percent effectiveness at preventing moderate to severe illness by the variant in Brazil and 64 percent effectiveness against the South African variant.
Johnson & Johnson stated that it could ‘provide 20 million doses by the end of March and 100 million by summer.’
Considering that it is a one dose and doesn’t need to be stored in a freezer, this will make it easier for developing countries and for the world to reach herd immunity.